What about the public funding that led to research and presumably went towards some of the failed attempts?
It sounds like there’s simply not enough information to gauge if pharmaceutical companies are being honest about their claims of R&D costs.
It sounds like there’s simply not enough information to gauge if pharmaceutical companies are being honest about their claims of R&D costs.
Pharma R&D companies that are publicly listed should have some information about their balance sheets.
Private equity ones are going to be the most opaque. That's kind of their prerogative.